O36.0932 Maternal care for other rhesus isoimmunization, third trimester, fetus 2

Name of the Condition

• Maternal care for other rhesus isoimmunization, third trimester, fetus 2
• ICD Code: O36.0932

Summary

This condition involves medical care and monitoring provided to a pregnant woman during the third trimester who has developed antibodies against the Rh factor, excluding anti-D antibodies, and is carrying a second fetus. The care focuses on managing potential risks to the fetus and ensuring maternal health, particularly when other Rh antibodies are present in late pregnancy for a multiple gestation.

Causes

Rhesus isoimmunization occurs when an Rh-negative mother is exposed to Rh-positive fetal blood, typically during a previous pregnancy or delivery. This exposure triggers the mother's immune system to produce antibodies that can cross the placenta and attack the red blood cells of an Rh-positive fetus in subsequent pregnancies. In this case, the antibodies are not anti-D but other Rh-specific antibodies, and the pregnancy involves a second fetus.

Risk Factors

• Previous pregnancy with an Rh-positive fetus
• Blood transfusion with Rh-positive blood
• Abdominal trauma during pregnancy
• Invasive prenatal procedures (e.g., amniocentesis)
• Prior miscarriage or ectopic pregnancy involving an Rh-positive fetus

Symptoms

• Often asymptomatic in the mother
• Fetal anemia, jaundice, or hydrops fetalis in severe cases
• Elevated bilirubin levels in the newborn

Diagnosis

Blood typing and antibody screening to detect non-anti-D Rh antibodies. Doppler ultrasound to assess fetal blood flow and anemia. Amniocentesis or cordocentesis may be used to evaluate fetal hemoglobin levels and antibody effects.

Treatment Options

• Close monitoring of fetal well-being through ultrasound and non-stress tests
• Administration of intravenous immunoglobulin (IVIG) to reduce antibody levels
• In severe cases, intrauterine blood transfusion for the fetus
• Planning for early delivery if fetal distress is detected

Prognosis and Follow-Up

With proper monitoring and intervention, outcomes for the fetus can be favorable. Follow-up care includes continued surveillance of fetal growth and anemia, as well as postnatal monitoring for jaundice or other complications. Maternal antibody levels may be tracked in subsequent pregnancies.

Complications

• Severe fetal anemia leading to hydrops fetalis
• Preterm birth
• Neonatal jaundice requiring exchange transfusion
• Increased risk of fetal or neonatal mortality

Lifestyle & Prevention

• Rh-negative women should receive Rh immune globulin (RhIg) after any potential sensitizing events, though this is less effective for non-D antibodies.
• Avoid unnecessary invasive procedures during pregnancy to reduce exposure risk.
• Early prenatal care to identify and manage Rh incompatibility.

When to Seek Professional Help

• Unusual fetal movement or reduced activity
• Signs of preterm labor
• Abdominal pain or bleeding
• Concerns about fetal well-being during routine monitoring

Tips for Medical Coders

This code is specific to maternal care for other rhesus isoimmunization in the third trimester for a second fetus. Documentation should clearly indicate the trimester, the presence of non-anti-D Rh antibodies, and the multiple gestation (fetus 2). Ensure the medical record supports the need for specialized monitoring or interventions related to Rh incompatibility.